CRON
Price
$2.63
Change
-$0.01 (-0.38%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.02B
40 days until earnings call
OGI
Price
$1.72
Change
-$0.03 (-1.71%)
Updated
Sep 26, 04:43 PM (EDT)
Capitalization
235.3M
Interact to see
Advertisement

CRON vs OGI

Header iconCRON vs OGI Comparison
Open Charts CRON vs OGIBanner chart's image
Cronos Group
Price$2.63
Change-$0.01 (-0.38%)
Volume$16.05K
Capitalization1.02B
Organigram Global
Price$1.72
Change-$0.03 (-1.71%)
Volume$800
Capitalization235.3M
CRON vs OGI Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. OGI commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Buy and OGI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CRON: $2.64 vs. OGI: $1.75)
Brand notoriety: CRON and OGI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 51% vs. OGI: 87%
Market capitalization -- CRON: $1.02B vs. OGI: $235.3M
CRON [@Pharmaceuticals: Generic] is valued at $1.02B. OGI’s [@Pharmaceuticals: Generic] market capitalization is $235.3M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRON and OGI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 4 bearish.
  • OGI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OGI is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -1.12% price change this week, while OGI (@Pharmaceuticals: Generic) price change was -6.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.63%. For the same industry, the average monthly price growth was +25.30%, and the average quarterly price growth was +68.14%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.63% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.02B) has a higher market cap than OGI($235M). OGI has higher P/E ratio than CRON: OGI (201.85) vs CRON (52.80). CRON YTD gains are higher at: 30.693 vs. OGI (8.696). OGI has higher annual earnings (EBITDA): -959K vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. OGI (36.8M). CRON has less debt than OGI: CRON (2.01M) vs OGI (9.15M). OGI has higher revenues than CRON: OGI (224M) vs CRON (130M).
CRONOGICRON / OGI
Capitalization1.02B235M432%
EBITDA-25.58M-959K2,668%
Gain YTD30.6938.696353%
P/E Ratio52.80201.8526%
Revenue130M224M58%
Total Cash834M36.8M2,266%
Total Debt2.01M9.15M22%
FUNDAMENTALS RATINGS
CRON vs OGI: Fundamental Ratings
CRON
OGI
OUTLOOK RATING
1..100
7919
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9189
PRICE GROWTH RATING
1..100
4141
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (68) in the Pharmaceuticals Other industry is in the same range as OGI (87) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as OGI (100) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

OGI's SMR Rating (89) in the null industry is in the same range as CRON (91) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's Price Growth Rating (41) in the null industry is in the same range as CRON (41) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's P/E Growth Rating (1) in the null industry is in the same range as CRON (6) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONOGI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSHZY9.48N/A
N/A
Hoshizaki Corporation
COLDF0.17N/A
N/A
Cardno Ltd.
ETOLF1.04N/A
N/A
Enterprise Group, Inc.
MRAAY9.36-0.02
-0.21%
Murata Manufacturing Inc.
ALKEF0.73-0.04
-5.66%
Alkane Resources Limited

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-2.58%
TLRY - CRON
60%
Loosely correlated
-5.56%
OGI - CRON
58%
Loosely correlated
-3.31%
CGC - CRON
57%
Loosely correlated
-3.52%
ACB - CRON
54%
Loosely correlated
-4.44%
EBS - CRON
31%
Poorly correlated
+5.43%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been loosely correlated with ACB. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if OGI jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-3.31%
ACB - OGI
63%
Loosely correlated
-4.44%
CGC - OGI
61%
Loosely correlated
-3.52%
TLRY - OGI
60%
Loosely correlated
-5.56%
CRON - OGI
59%
Loosely correlated
-2.58%
HROW - OGI
35%
Loosely correlated
-3.61%
More